The Firm

Horn & Co. is the leading Israeli boutique law firm in the field of hi-tech and life sciences and is unique in its exclusive practice and expertise in this field. The firm’s founder, Yuval Horn, was recognized by the International Who’s Who of Life Sciences Lawyers as a Global Elite Thought Leader (2018-2021) and as one of the five leading individuals in the world in life sciences transactions (2013, 2015).

Horn & Co.’s expertise includes the representation of clients in all aspects of their operations, focusing especially on their technology and intellectual property transactions, corporate and funding matters and commercial contracting.

Horn & Co. was founded in September 2009 and currently employs 18 lawyers and two articled clerks. The firm is known for its tailored, innovative structures, solutions and advice in complex transactions and situations. Since 1993, both Yuval and his colleagues have represented numerous founders, companies and investors in their transactions in the life science and technology sectors.

Horn & Co. is the Israeli member of Biolegis, a network of leading European law firms with specific expertise in the representation of biotechnology and medical device companies. The firm’s partners and associates have been recognized by the leading international publications and peers as experts in corporate law, intellectual property and technology transactions and are typically asked to lecture and write about these areas. Horn & Co. has been recognized by Legal 500 as a “Tier 1” firm in Israel in the field of Healthcare and Life Sciences noting that: “the firm has been active at the ‘top level’ in the healthcare sector for over 20 years”.

Since 2008 Yuval has been a member and legal advisor of the Institutional Review Board (Helsinki Committee) of the Chaim Sheba Medical Center at Tel-Hashomer. Yuval served as the Co-Chair of the International Bar Association (IBA) Technology Law Committee (2016-2017), is a member of the Executive Committee of the IBA Annual World Life Sciences Conference and a co-chairman of the IBA Annual M&A in the Technology Sector Conference.


The firm has been consistently ranked and designated by the leading global publications as a leader in its field of expertise. such publications include:

Horn & Co. was ranked as a Tier 1 firm in Intellectual Property Transactions by Dun and Bradstreet;

Horn & Co. was ranked as a Tier 1 firm in High tech by Dun and Bradstreet;

Yuval Horn was ranked a Global Elite Thought Leader in Life Sciences Transactions in Life Sciences Transactions in 2020 by Who’s Who Legal (also in 2019, 2018, 2015 and 2013) – the only Israeli who achieved this recognition.

Yuval Horn noted as one of the 3 top practitioners in Israel in IP transactions by International Asset Magazine.

Horn & Co. was ranked Tier 1 in IP Transactions by International Asset Magazine. The recent publication noted as follows:

Horn & Co’s technical breadth means that it can cater to an expansive range of clients, while the depth of each practitioner’s expertise still promises quality. On this year’s agenda has been the completion of a research and collaboration agreement on behalf of Anima Biotech with Eli Lilly (worth more than $1 billion in total), the representation of Vascular Biogenics Ltd in commercial agreements with Nanocarrier Co Ltd and the continued supply of high-level data protection advice to Zebra Medical Vision. Horn has been described as someone you would want on your team rather than on the other side: he is “one of the best IP transactional lawyers in Israel”, according to a recent client with decades of experience in the local market. “He is knowledgeable and experienced, very practical, solves problems rather than creating them and is very nice to work with.” The same is said for Mamann, who is also highly regarded for his outstanding work on cross-border transactions. Keren Kanir brings an international touch to the practice, having been awarded an LLM in the United States.

Horn & Co. was ranked as a Tier 2 firm (together with some of Israel’s largest firms) in M&A by Dun and Bradstreet;

Yuval Horn was ranked as a Global Leader in Data in 2020 by Who’s Who Legal.

Chambers ranked our firm in TMT and Fintech (there is no ranking for life sciences). The 2020 guide states:

Yuval Horn is particularly recognised for his work in the biotech and fintech spaces. He provides counsel on various acquisition and investment transactions, as well as financing mandates. “He is a good lawyer,” states a market insider, adding: “He has an amazing practice, good clients, knows the field inside out and is a smart person.”